LexisNexis® Legal News Podcast for January 16, 2009

Lilly settles Zyprexa off-label claims for $1.4 billion, and, UnitedHealth will pay $50 million to settle a fee dispute. Hear these and other stories from LexisNexis® Mealey’s™ Emerging Drugs Devices, Managed Care, IP, Pollution Liability, Real Estate and Class Actions Reports. Copyright© 2009 LexisNexis, a division of Reed Elsevier Inc. For the latest litigation news headlines, go to www.lexisnexis.com/mealeys.

No related posts.

FREE Case Review

Defective DrugsAdverse reactions to medications on the market.

Personal InjuryPersonal injuries resulting from negligence may lead to significant medical expenses.

Toxic ExposureDangerous toxins linked to cancers, birth defects, and chronic respiratory problems.

DiseasesDangerous toxins linked to cancers, birth defects, and chronic respiratory problems.

Financial FraudsUnethical actions by large corporations may cause financial hardship.

Medical MalpracticeMedical errors or negligent health care resulting in injury or death.

LexisNexis® Legal News Podcast for January 16, 2009

FREE Case Review

Trending Topics